"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","age:ch1","diagnosis:ch1","tissue:ch1"
"GSM3904621","LONZA_BMSC_exo_old_1","GSM3904621","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","elderly donors (age of donor: 68 years)","Homo sapiens","diagnosis: normal","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 68 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","control","normal_BMSC_1_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","normal","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904622","LONZA_BMSC_exo_old_2","GSM3904622","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","elderly donors (age of donor: 72 years)","Homo sapiens","diagnosis: normal","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 72 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","control","normal_BMSC_2_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","72 years","normal","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904623","MDS_BMSC_exo_UPN33","GSM3904623","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 51 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 51 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_33_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","51 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904624","MDS_BMSC_exo_UPN54","GSM3904624","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 58 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 58 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_54_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","58 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904625","MDS_BMSC_exo_UPN59","GSM3904625","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 55 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 55 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_59_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","55 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904626","MDS_BMSC_exo_UPN82","GSM3904626","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 78 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 78 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_82_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","78 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904627","MDS_BMSC_exo_UPN95","GSM3904627","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 68 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 68 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_95_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904628","MDS_BMSC_exo_UPN93","GSM3904628","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 82 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 82 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_93_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","82 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904629","MDS_BMSC_exo_UPN101","GSM3904629","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 77 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 77 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_101_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","77 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904630","MDS_BMSC_exo_UPN102","GSM3904630","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 47 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 47 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_102_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","47 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904631","MDS_BMSC_exo_UPN103","GSM3904631","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 22 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 22 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_103_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","22 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904632","MDS_BMSC_exo_UPN107","GSM3904632","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 82 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 82 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_107_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","82 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904633","MDS_BMSC_exo_UPN64","GSM3904633","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 46 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 46 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_64_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","46 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904634","MDS_BMSC_exo_UPN141","GSM3904634","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 84 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 84 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_141_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","84 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904635","MDS_BMSC_exo_UPN115","GSM3904635","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 50 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 50 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_115_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","50 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904636","MDS_BMSC_exo_UPN8","GSM3904636","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 72 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 72 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_8_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","72 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904637","MDS_BMSC_exo_UPN12","GSM3904637","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 38 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 38 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_12_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","38 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904638","MDS_BMSC_exo_UPN58","GSM3904638","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 71 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 71 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_58_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","71 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904639","MDS_BMSC_exo_UPN22","GSM3904639","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 66 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 66 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_22_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","66 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904640","MDS_BMSC_exo_UPN44","GSM3904640","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 72 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 72 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_44_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","72 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904641","MDS_BMSC_exo_UPN38","GSM3904641","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 56 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 56 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_38_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","56 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904642","MDS_BMSC_exo_UPN120","GSM3904642","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 68 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 68 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_120_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904643","MDS_BMSC_exo_UPN108","GSM3904643","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 87 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 87 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_108_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","87 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904644","MDS_BMSC_exo_UPN175","GSM3904644","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","MDS patient (age of donor: 68 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 68 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_175_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","68 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904645","MDS_BMSC_exo_UPN4","GSM3904645","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 77 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 77 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_4_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","77 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904646","MDS_BMSC_exo_UPN30","GSM3904646","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 72 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 72 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_30_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","72 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904647","MDS_BMSC_exo_UPN13","GSM3904647","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 61 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 61 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_13_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","61 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904648","MDS_BMSC_exo_UPN18","GSM3904648","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 67 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 67 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_18_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","67 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904649","MDS_BMSC_exo_UPN127","GSM3904649","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 64 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 64 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_127_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","64 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904650","MDS_BMSC_exo_UPN133","GSM3904650","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 67 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 67 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_133_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","67 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
"GSM3904651","MDS_BMSC_exo_UPN98","GSM3904651","Public on Jun 26 2019","Jun 25 2019","Jun 26 2019","RNA","1","AML patient (age of donor: 42 years)","Homo sapiens","diagnosis: myelodysplastic syndrome (MDS)","tissue: exosomal miRNAs of human bone marrow stromal cells","age: 42 years","The exosomes from culture medium of BMSCs were isolated by Total exosome isolation reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for subsequent analysis.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","MDS_BMSC_98_exo","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","42 years","myelodysplastic syndrome (MDS)","exosomal miRNAs of human bone marrow stromal cells"
